White label ELPA - ClinicalTrials.eu

Study on Setmelanotide for Improving Hypothalamic Function in Patients with ROHHAD Syndrome

Recruiting

2 1 1 1
Investigated diseases:
- ROHHAD syndrome
Investigated drugs:
- Setmelanotide
Study on the Effects of Ensifentrine for Patients with Non-Cystic Fibrosis Bronchiectasis

Recruiting

2 1
Investigated diseases:
- Bronchiectasis
Investigated drugs:
- ENSIFENTRINE
Study of alpha-1 antitrypsin given intravenously to hospitalized patients during COPD exacerbation

Recruiting

2 1 1
Investigated diseases:
- Chronic obstructive pulmonary disease
Investigated drugs:
- Human Alpha1-Proteinase Inhibitor
- Sodium Chloride
Study on Dupilumab and Fexofenadine for Treating Indolent Systemic Mastocytosis with Skin Involvement in Patients

Recruiting

3 1 1
Investigated diseases:
- Systemic mastocytosis
Investigated drugs:
Study of Gadobutrol for MRI in Adults with Cerebrospinal Fluid Disorders, Including Hydrocephalus and Brain Tumors

Recruiting

3 1 1 1
Investigated diseases:
Investigated drugs:
- Gadobutrol
Study on Telmisartan for Reducing Portal Hypertension in Patients with Advanced Chronic Liver Disease

Recruiting

2 1 1
Investigated drugs:
- Telmisartan
Study on the Effectiveness of Clarithromycin and Other Drug Combinations for Patients with Uncomplicated Staphylococcus aureus Blood Infection

Recruiting

3 1 1 1
Investigated diseases:
- Staphylococcal bacteraemia
Investigated drugs:
Study of TIL therapy combined with peginterferon alfa-2a and nivolumab for patients with metastatic melanoma

Recruiting

1 1 1 1
Investigated diseases:
- Metastatic malignant melanoma
Investigated drugs:
- TIL CELLS
- Zirconium (89Zr) Crefmirlimab Berdoxam
Study on the Effectiveness and Safety of AZD0486 for Adults with Relapsed or Refractory Non-Hodgkin Lymphoma

Recruiting

2 1 1
Investigated diseases:
Investigated drugs:
- Human Igg4 Kappa Monoclonal Antibody Against Cd3 And Cd19
Study on the Effectiveness of Ublituximab and Drug Combination for Patients with Relapsing Multiple Sclerosis

Recruiting

3 1 1
Investigated diseases:
- Relapsing multiple sclerosis
Investigated drugs:

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies